Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000113

EVP Research and Development gave up 18,441 shares (to pay taxes)

  • EVP Research and Development acquired 23,638 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STAHL NEIL · EVP Research and Development

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-02 Exercise or conversion : show line 1 in the form +23,638 $555.67 $13,134,927 74,637 D
2024-08-02 Shares withheld for taxes : show line 2 in the form −18,441 $1,093.49 $20,165,049 56,196 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-02 Exercise or conversion : show line 3 in the form Non-Qualified Stock Option (right to buy) −23,638 45,000 D
Loading xslF345X05/edgardoc.xml…